ASCO GU: Robotic Surgery Changes Some Prostate CA Treatment

Vaccine Eyed for Early-Stage Prostate Ca
SAN FRANCISCO (MedPage Today) -- The immunotherapy agent sipuleucel-T (Provenge) appears safe for use earlier in prostate cancer, researchers found.

Most Common Tx for Prostate Ca Not Best Value
SAN FRANCISCO (MedPage Today) -- External beam radiation is the most toxic and expensive among common prostate cancer treatments over the long-term, a national registry study suggested.

AUA: Surgery Works in Locally Advanced Prostate...
WASHINGTON (MedPage Today) -- Men with locally advanced prostate cancer had a 20-year disease-specific survival of 81% following radical prostatectomy, data from a large clinical series...

Burt's Bees Free Head to Toe Starter Kit

Lobe Wonder Ear Support Patches For Earrings,...